COPD

COPD is the single largest condition in our BVA dataset: 3,218 cases. The grant rate is 30 percent. The denial rate is essentially tied with it. The remand rate (39 percent) is the highest of the three. More than one in three COPD appeals goes back for additional development, usually because the C&P exam wasn't good enough to decide the case in front of the Board. The medicine is rarely the limiting factor on a COPD claim. The pulmonary function test gives the rater a number, and 38 CFR § 4.97 hands the rater a paint-by-numbers ladder. What kills these claims is the bridge between the lungs you have today and the service you did decades ago.

The cross-tab tells the whole story. Strong nexus grants at 93 percent. Weak nexus grants at 7 percent. That's not a curve, it's a cliff. And the C&P exam fails to address the in-service exposure history about 70 percent of the time, well above the 52 percent average we see across all conditions. Most COPD denials aren't about a missing diagnosis or insufficient severity. They're about a nexus opinion that doesn't engage with what happened during service, often because the examiner pinned everything on smoking history and stopped there.

There's a presumptive lane that bypasses the nexus question entirely. COPD is expressly listed in 38 USC § 1120 for a covered veteran under 38 USC § 1119. That statutory presumption is the authority for COPD itself. It is separate from 38 CFR § 3.320, which uses narrower service criteria and does not list COPD. The Agent Orange disease list also does not make COPD presumptive. Veterans who do not meet the § 1119 and § 1120 criteria can still pursue direct service connection, including a toxic-exposure-risk-activity opinion when applicable. This page covers the four-tier rating ladder under DC 6604, the nexus cliff, the C&P inadequacy pattern, and the difference between a valid presumption and a direct-exposure theory.

TL;DR

• COPD is the largest single condition in our BVA dataset: 3,218 cases. Outcomes split granted 30.4%, denied 30.7%, remanded 38.9%.
• Nexus quality is the dominant variable. Strong nexus grants at 92.5%. Weak nexus grants at 6.9%. Missing nexus grants at 5.7%.
• "Nexus gap" is the top denial reason: 530 cases, roughly 38% of classified denials.
• 69.4% of COPD C&P exams in this dataset were flagged inadequate, well above the 52.0% rate across all conditions.
• Cases coded as presumptive grant at 43.2%, the highest connection type for COPD. For current claims, the COPD-specific toxic-exposure presumption comes from 38 USC §§ 1119 and 1120, not the Agent Orange list or 38 CFR § 3.320.
• The 100% rating shows up more often than most people realize. Among COPD claims granted with a rated tier, 30% is the modal rating and 100% is the second-most common.

COPD Is the Biggest Single Condition in the Dataset

When we sorted 101,518 condition records drawn from 49,876 Board decisions by condition, COPD came out on top. 3,218 cases. That's bigger than the PTSD bucket as it's coded in this dataset, bigger than sinusitis, bigger than tinnitus appeals, bigger than everything.

That number alone tells you something. COPD isn't a rare claim. It isn't an exotic claim. It's a workhorse condition that veterans file every day, and the patterns we see in the Board's decisions are the patterns the rest of VA uses when it processes the same claim at the regional office level.

The headline outcome split is almost evenly distributed between granted and denied, with a heavy lean toward remand:

• Granted: 978 cases (30.4%)
• Denied: 987 cases (30.7%)
• Remanded: 1,253 cases (38.9%)

The 38.9% remand rate is the number to sit with. More than one in three COPD appeals goes back for development, usually because the C&P exam wasn't good enough, the nexus wasn't addressed, or the file is missing something the Board needs to decide. That's a lot of waiting. A remand isn't a denial, but it isn't a grant either. It's the procedural reset button, and it adds years to the process.

We'll come back to remands. For now, the point is that COPD lives in the messy middle of the Board's docket: high volume, high uncertainty, and a structure where the medicine is rarely the limiting factor.

DC 6604 and the Pulmonary Function Test Tiers Under 38 CFR § 4.97

COPD is rated under 38 CFR § 4.97, Diagnostic Code 6604. That regulation is the most mechanical rating schedule in the respiratory chapter. There's no "describe your impairment narratively" component. There's a pulmonary function test, and the test results map to a rating tier.

The four rating tiers

The four rating tiers under DC 6604 are:

• 10%: FEV-1 of 71 to 80 percent predicted, or the ratio of FEV-1 to FVC of 71 to 80 percent, or DLCO (SB) of 66 to 80 percent predicted.
• 30%: FEV-1 of 56 to 70 percent predicted, or FEV-1/FVC of 56 to 70 percent, or DLCO of 56 to 65 percent.
• 60%: FEV-1 of 40 to 55 percent predicted, or FEV-1/FVC of 40 to 55 percent, or DLCO of 40 to 55 percent, or maximum exercise capacity of 15 to 20 ml/kg/min with cardiac or respiratory limitation.
• 100%: FEV-1 less than 40 percent predicted, or FEV-1/FVC less than 40 percent, or DLCO less than 40 percent, or maximum exercise capacity less than 15 ml/kg/min, OR cor pulmonale, OR right ventricular hypertrophy, OR pulmonary hypertension, OR episodes of acute respiratory failure, OR the requirement of outpatient oxygen therapy.

Notice how the ladder expands. The 10% and 30% tiers are pure PFT math, the 60% tier also permits the exercise-capacity criterion, and the 100% tier picks up cor pulmonale, oxygen therapy, and respiratory failure, which is why the 100% rating is more common than people expect.

Rating-tier distribution in the BVA grants

Among COPD grants where a rating tier was coded, the distribution looks like this:

• 0%: 17 cases
• 10%: 53 cases
• 30%: 62 cases (the modal tier)
• 60%: 37 cases
• 70%: 39 cases (rated via combinations or transitional values)
• 100%: 65 cases

The 30% rating is the most common, which fits the PFT distribution of veterans with chronic but managed COPD. The 100% rating is the second-most common, which fits the population of veterans who end up in front of the Board with oxygen prescriptions and pulmonary hypertension on their records. The middle tiers (10% and 60%) are smaller buckets, partly because those PFT ranges are narrower and partly because veterans whose function falls in those windows often settle at the regional office without appealing.

DC 6604 doesn't have a 50%. It jumps from 30 to 60, and then from 60 to 100. That structural feature creates real money on the table. A veteran whose FEV-1 sits at 56 percent predicted gets the same 30% rating as a veteran whose FEV-1 sits at 70 percent. A single point of decline from 56 to 55 jumps them to 60%. The C&P examiner's PFT report becomes the rating, more or less.

The Nexus Gap Drives 38 Percent of Denials

This is the part of the dataset that shapes how we think about COPD claims more than anything else.

Across the 3,218 cases, the cross-tab between nexus quality and grant rate is brutal:

• Strong nexus: 347 cases, 92.5% grant
• Adequate nexus: 513 cases, 80.7% grant
• Weak nexus: 1,098 cases, 6.9% grant
• Missing nexus: 460 cases, 5.7% grant
• Not applicable (presumptive/other path): 800 cases, 17.6% grant

Read that again.

Strong nexus grants at 92.5 percent. Weak nexus grants at 6.9 percent. The drop between the two isn't a curve, it's a cliff. Adequate-to-weak is the canyon, and weak-to-missing is the floor everyone falls onto if they fail in the right way.

And when we sort denials by the reason the Board names, "nexus gap" is the biggest single category:

• nexus_gap: 530 cases (roughly 38% of classified denials)
• other: 493
• service_connection_missing: 134
• diagnosis_missing: 120
• severity_insufficient: 110

Diagnosis missing is small. Severity insufficient is small. The lungs are usually there and the PFT is usually there. What's not there is the bridge: the medical opinion that says, in so many words, "this COPD is at least as likely as not the result of an in-service exposure or condition." Without that bridge, the claim sits on the wrong side of the canyon.

A caveat is in order. Nexus quality is something the Board codes after reading the whole file, so the variable carries some hindsight in it. Strong nexus didn't cause the grant in the same way pulling a trigger fires a bullet. The strong-nexus cases are also the cases where the rest of the evidence tends to be cleaner. But even with that caveat, the 92.5-versus-6.9 spread is too wide to be selection bias alone. The Board is telling us, in pattern after pattern, that the nexus opinion is what tips most close COPD cases.

For veterans filing today, the practical reading of this is unambiguous. The pulmonary function test gets you the rating. The nexus letter gets you the claim. Don't conflate the two.

C&P Inadequacy Is Higher Here Than Average

The other variable that shapes COPD outcomes more than expected is how often the Board finds the C&P exam inadequate.

Across all 101,518 condition records drawn from 49,876 Board decisions in our dataset, the inadequacy rate is 52.0 percent. For COPD specifically, it's 69.4 percent. That's a 17-point tilt toward inadequacy for this condition.

What makes a C&P exam inadequate for COPD? In the decisions we read, the patterns repeat. The examiner doesn't address the in-service exposure history with any specificity. The examiner notes a smoking history and stops there, without explaining why the in-service exposures would or wouldn't have contributed alongside the smoking. The examiner uses boilerplate language like "more likely due to long-standing tobacco use" without engaging with the medical literature on cumulative exposure. The examiner doesn't review the service treatment records that show respiratory complaints during active duty.

When the Board flags a COPD exam as inadequate, the outcomes shift. Across the full dataset, inadequate-exam cases grant or remand at 81.8 percent. Adequate-exam cases grant or remand at 39.7 percent. The remand portion of that statistic is doing most of the work, because when an exam is inadequate, the Board usually sends it back for a better one rather than granting outright.

For COPD specifically, this is part of why the remand rate is so high. The exam doesn't address what it needs to address, the Board can't decide on the file in front of it, and the case goes back for development. The veteran then waits another year or two for a second C&P, and the cycle either resolves with a better opinion or repeats.

The honest read is that COPD claims are exposed to an unusually high rate of examiner under-engagement. The condition is common enough that examiners run through it on autopilot. The smoking-history confounder gives examiners an easy off-ramp from doing the harder analytical work of separating in-service contribution from post-service contribution. And the PFT-based rating structure can make examiners feel like the medical opinion is less important because the numbers will sort the rating tier, even though the medical opinion is exactly what carries the service connection.

Presumption Helps When It Applies

Connection type matters a lot for COPD, and presumption is the cleanest path when a veteran qualifies.

Across the dataset:

• Direct service connection: 1,510 cases, 38.7% grant
• Presumptive: 488 cases, 43.2% grant (the highest)
• Secondary: 341 cases, 38.4% grant
• Aggravation: 19 cases, 42.1% grant

The presumptive lane wins more often than the direct lane because a valid statutory shortcut takes the nexus question off the table. For COPD, 38 USC § 1120 lists the disease for a covered veteran as defined by 38 USC § 1119, subject to the rebuttal rules incorporated from 38 USC § 1113.

The exposure or presumptive categories invoked in the COPD subset:

• Herbicide / Agent Orange exposure: roughly 807 cases (619 plus 188 in the combined Agent Orange categories)
• Burn pit exposure: 359 cases
• Gulf War undiagnosed illness: 83 cases
• Camp Lejeune contaminated water: 62 cases

Those labels describe how the Board decisions were coded, not a finding that every invoked theory was legally available. COPD is not on the Agent Orange disease list, and diagnosed COPD is not automatically a Gulf War undiagnosed illness or a Camp Lejeune presumptive disease. The current COPD disease presumption is the 38 USC § 1120 toxic-exposure presumption for veterans who meet § 1119's covered-service criteria. Other exposure histories can still support direct service connection when the evidence supplies a nexus.

That brings us to the part of the PACT Act that catches veterans off-guard.

The PACT Act Expressly Lists COPD

The PACT Act added a toxic-exposure disease presumption for covered veterans. Section 1119 defines the covered service and presumed exposure. Section 1120 supplies the disease presumption and expressly lists chronic obstructive pulmonary disease.

That means COPD itself is presumptive when the veteran and service meet 38 USC §§ 1119 and 1120. A clinician does not have to relabel COPD as chronic bronchitis, emphysema, or constrictive bronchiolitis to put an otherwise qualifying COPD claim on that statutory lane.

Chronic bronchitis, asthma diagnosed after covered service, emphysema, and constrictive or obliterative bronchiolitis are separately listed too. The statute also covers respiratory cancer of any type. Those entries do not narrow or replace the separate COPD entry.

Clinical precision still matters because COPD, chronic bronchitis, emphysema, and bronchiolitis can coexist and can produce different treatment and rating evidence. But a correct COPD diagnosis already fits § 1120's disease list.

The distinction between the statute and the regulation matters too. Section 1120 is the broad statutory disease list. Section 3.320 is a separate regulation with narrower qualifying-service rules and a shorter list of respiratory diseases and rare respiratory cancers; it is not the source of the COPD presumption.

If VA denies a COPD presumption, the first questions are whether the veteran satisfies § 1119's covered-service definition and whether VA applied § 1120. If those requirements are not met, the claim may still proceed directly with evidence connecting the diagnosed COPD to an in-service event or toxic exposure.

The 359 burn-pit-coded cases show that toxic-exposure theories already appear in the appellate record, but the coding does not establish whether the correct authority was applied in each historical decision.

What Actually Wins COPD Claims at the Board

If we had to summarize what the 3,218 cases tell us about the COPD claim that wins, it comes down to four things.

One: A pulmonary function test that captures current severity. The PFT is what gets you the rating tier. The numbers are what they are. Get the test done, get it documented, and make sure the FEV-1, FEV-1/FVC, and DLCO values are in the file. If the C&P examiner's PFT and your private PFT differ meaningfully, that's a fight worth having.

Two: A nexus opinion that engages with the in-service exposure. The 92.5% grant rate at strong nexus isn't an accident. The Board reads the medical opinion, looks for engagement with the specific exposure history, and weighs whether the opinion explains the medical pathway. "More likely than not related to military service" by itself is not a strong nexus. "More likely than not related to military service because the veteran's documented in-service respiratory complaints, the specific airborne hazards in his service location, and the time course of his symptom development collectively support an etiologic link" is a strong nexus. The difference is articulation.

Three: Use the exact presumption when it applies. For COPD, the current toxic-exposure presumption is 38 USC §§ 1119 and 1120. Agent Orange and Camp Lejeune do not make COPD itself presumptive, and a diagnosed COPD claim is not automatically a Gulf War undiagnosed illness. Veterans outside the § 1119 and § 1120 lane can still use direct service connection, including toxic-exposure evidence and a medical opinion that addresses it. The presumptive grant rate of 43.2% versus the direct rate of 38.7% understates the practical benefit when a valid presumption applies because it removes the nexus question entirely.

Four: Push back when the C&P exam is inadequate. A 69.4% inadequacy rate means most veterans get an exam that doesn't address what it needs to address. If your C&P opinion is short, doesn't engage with your service history, and doesn't explain the medical reasoning, the Board has consistently treated that as inadequate under the Barr v. Nicholson framework. You can request a supplemental opinion or submit a private nexus letter that does the analytical work the VA examiner skipped.

None of this is a guarantee. The 30.4% grant rate at the Board is the same 30.4% no matter how clean your file is. But the structural variables that move outcomes are knowable, and most of them are addressable.

COPD vs. Chronic Bronchitis: Clinical Precision Still Matters

COPD is an umbrella label. Chronic bronchitis, emphysema, and constrictive bronchiolitis can all sit under that larger clinical family, and the chart should identify the diseases the veteran actually has. But COPD, chronic bronchitis, emphysema, and constrictive or obliterative bronchiolitis are each expressly listed in 38 USC § 1120. A qualifying COPD claim does not depend on substituting a different diagnosis.

This is not wordplay. It is a clinical question. Chronic bronchitis is usually tied to chronic productive cough, airway inflammation, and sputum production. Emphysema has a different pathologic pattern. Constrictive bronchiolitis has another. Accurate diagnoses help VA rate the actual impairment and avoid overlooking a coexisting disease, even though § 1120 already names COPD.

For veterans whose respiratory picture overlaps with asthma or sinusitis, the file should be precise about which diagnosis is primary, which is secondary, and which lane each condition belongs in.

What a Strong Nexus Letter Has to Cover for a COPD Claim

A strong COPD nexus letter does four things. It identifies the specific in-service exposures, such as burn pits, JP-8 fuel, asbestos, dust storms, shipyard exposure, herbicides, or documented respiratory complaints. It explains the time course from service to symptoms to diagnosis. It addresses competing causes, especially smoking history and post-service occupational exposures. And it cites the medical reasoning that connects the exposure pattern to the current obstructive disease.

The weak version is a one-line conclusion: "COPD is related to service." The stronger version explains why the veteran's service exposure was at least as likely as not a contributing cause, even when other risk factors exist. VA does not require military service to be the only cause. The file has to explain why it is at least a contributing cause.

An evidence checklist for nexus letters and buddy statements for in-service exposure can help build the factual record before a pulmonologist or occupational-medicine physician writes the opinion.

Reading Your PFT: FEV-1, FEV-1/FVC, DLCO

The COPD rating starts with the pulmonary function test. FEV-1 measures how much air you can force out in the first second. FEV-1/FVC compares that first-second output to total forced capacity. DLCO measures how well oxygen transfers from the lungs into the blood. Under DC 6604, any one of those numbers can drive the rating tier.

The cliff matters. A veteran with FEV-1 at 56 percent predicted sits at 30 percent. A veteran at 55 percent moves to 60 percent. A veteran below 40 percent, on outpatient oxygen, with pulmonary hypertension, cor pulmonale, right ventricular hypertrophy, acute respiratory failure episodes, or very low exercise capacity can reach 100 percent.

If your private PFT and VA C&P PFT differ, do not assume the lower rating is fixed. The file should explain test quality, bronchodilator use, whether DLCO was performed, and which value best captures functional severity. A respiratory C&P exam prep pass is useful before the exam because the rating is only as good as the numbers VA records.

When the C&P Exam Is Inadequate: How to Push Back

The most common inadequate COPD exam does not ignore the lungs. It ignores service. The examiner notes smoking history, documents the PFT, and then writes a short negative opinion without engaging with airborne hazards, respiratory complaints during service, occupational exposures, or the relevant presumptive framework.

Under the Barr v. Nicholson adequacy standard, VA has to provide an exam that is factually accurate, fully articulated, and based on sound reasoning once it chooses to provide one. A COPD opinion that does not address the veteran's actual exposure history is usually vulnerable. So is an opinion that treats smoking as a complete answer without explaining whether service exposure also contributed.

The pushback should be specific: what exposure history was missed, which records were not discussed, what diagnostic label was ignored, and why the rationale does not answer the service-connection question. In some cases, a private nexus opinion is faster than waiting for another generic supplemental C&P.

COPD Secondary Conditions Worth Filing

COPD can produce or aggravate other compensable conditions. Pulmonary hypertension, cor pulmonale, oxygen dependence, depression from chronic illness, sleep disruption, and chronic sinus disease all appear in COPD files. Sleep apnea is a common COPD secondary, especially when oxygen desaturation, obesity, medication effects, or overlapping respiratory mechanics are documented. Hypertension secondary to chronic respiratory disease and depression secondary to chronic illness can also be plausible when the medical record supports the chain.

Do not file every possible secondary condition just because it exists on the internet. File the ones with diagnosis, symptoms, and a medical pathway. A secondary condition pathways from COPD review can help separate a real secondary claim from a condition that merely coexists.

Bottom Line

COPD is the largest single condition in our BVA dataset (3,218 cases) and the grant rate at the Board is 30.4 percent. The rating ladder under 38 CFR § 4.97 DC 6604 is mechanical: pulmonary function test results map to 10%, 30%, 60%, or 100% rating tiers, with the 100% tier picking up cor pulmonale and oxygen-therapy categories. The 30% tier is the modal rating among grants; the 100% tier is the second-most common. What separates direct-service-connection wins from losses is the nexus opinion. Strong nexus grants at 92.5 percent, weak nexus grants at 6.9 percent. C&P exam quality is flagged inadequate 69.4 percent of the time for COPD versus 52 percent overall. For a covered veteran, 38 USC §§ 1119 and 1120 expressly make COPD presumptive and remove the nexus question. Agent Orange, Camp Lejeune, and Gulf War coding in the dataset should not be mistaken for separate COPD presumptions. Veterans outside the statutory lane need the direct nexus evidence that the dataset shows is decisive.

Related Conditions

COPD overlaps most often with asthma, sinusitis, sleep apnea, hypertension, and depression. Veterans with multiple respiratory diagnoses should also review the secondary conditions tool before choosing which claim is primary and which claims are downstream.

Methodology and Limitations

• Data source: Outcome statistics, nexus-quality coding, denial-reason classification, C&P adequacy flags, and connection-type tagging are drawn from Claim Raven's analysis of 101,518 condition records drawn from 49,876 Board decisions, including 3,218 COPD cases. Rating tier framework is drawn from 38 CFR § 4.97, Diagnostic Code 6604. The COPD toxic-exposure presumption is drawn from 38 USC §§ 1119 and 1120. Direct toxic-exposure development is governed by 38 USC § 1168. Agent Orange, Gulf War, and Camp Lejeune categories are retained only as historical dataset tags and are not described as COPD disease presumptions.
• Sample size: 3,218 BVA decisions involving COPD, with outcomes split granted 30.4% (978 cases), denied 30.7% (987 cases), remanded 38.9% (1,253 cases). The data hero at the top of this page reflects favorable outcomes (granted, partial_grant, mixed) as a single bucket; the methodology section here breaks granted out separately.
• Limitations: The 3,218 COPD cases are cases that reached the BVA, not all COPD claims filed with VA. Claims granted at the regional office without appeal aren't in this dataset. Smoking history is a major non-service confounder for COPD and is not cleanly coded as a separate variable. Severity progression over time isn't captured. Nexus quality is coded post-hoc by reviewing the decision text. The PACT Act analysis here reflects regulatory framework, not predictions of how any specific claim will be decided. These observations describe BVA patterns and are not predictions of individual outcomes, and Claim Raven is data analysis, not legal, medical, or VA-accredited advice.